It is not uncommon for different countries to require at least part of a clinical trial be conducted in their country. The…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Biotechnology
-
-
RegulatoryU.S FDA
FDA Investigating Possible Death Risk Linked to TG Therapeutics’ Lymphoma Drug
by adminby adminSynopsis: The U.S. Food and Drug Administration announced it is investigating a possible death risk for TG Therapeutics’ Ukoniq (umbralisib). The drug…
-
AgrochemicalsGlobal MarketPharma Science & Research
Tiziana Announces Submission of Amendment to Investigational New Drug Application to Advance Oral Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, in Patients with Crohn’s Disease
by adminby adminSummary – – Tiziana is Developing the First Oral Form of Foralumab in a Convenient Capsule to be Evaluated in Phase 1b…
-
Pharma Science & Research
Current COVID-19 vaccines induce robust cellular immunity against Omicron variant
by adminby adminA highly mutated version of SARS-CoV-2, the virus that causes COVID-19, the Omicron variant has been shown to cause breakthrough infections among…
-
Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine;…
-
Active Pharmaceutical Ingredients (API)CompaniesGlobal MarketPAXLOVIDPfizer
COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
by adminby adminSummary : EMA’s human medicines committe has recommended granting conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 / ritonavir) for…
-
Global MarketRegulatoryU.S FDA
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
by adminby adminSynopsis : The U.S. Food and Drug Administration, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organizations have partnered…
-
AgrochemicalsGlobal Market
InvaGen to continue to hold shares in Avenue Therapeutics: Cipla
by adminby adminSynopsis : In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business…
-
Summary : The company will invest up ₹6 crore for the 33% stake in the target firm Cipla on Wednesday announced that…
-
Summary – The European Medicines Agency (EMA) has issued a list of about 100 regulatory science topics that need further research to close…